The nuclear medicine diagnostics market uses radiopharmaceuticals for non-invasive imaging to detect cancer, cardiac disorders, and neurological diseases. Increasing PET/CT scan adoption and advancements in molecular imaging technologies support market expansion. https://www.databridgemarketresearch.com/reports/global-nuclear-medicine-diagnostics-market